These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene products. Muchardt C, Seeler JS, Nirula A, Shurland DL, Gaynor RB. J Virol; 1992 Jan; 66(1):244-50. PubMed ID: 1727488 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S. J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279 [Abstract] [Full Text] [Related]
4. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J. J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193 [Abstract] [Full Text] [Related]
5. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB. Virology; 1997 Aug 18; 235(1):48-64. PubMed ID: 9300036 [Abstract] [Full Text] [Related]
6. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR. Seeler JS, Muchardt C, Podar M, Gaynor RB. Virology; 1993 Oct 18; 196(2):442-50. PubMed ID: 8372429 [Abstract] [Full Text] [Related]
7. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Majello B, De Luca P, Hagen G, Suske G, Lania L. Nucleic Acids Res; 1994 Nov 25; 22(23):4914-21. PubMed ID: 7800480 [Abstract] [Full Text] [Related]
8. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Desai-Yajnik V, Samuels HH. Mol Cell Biol; 1993 Aug 25; 13(8):5057-69. PubMed ID: 8393143 [Abstract] [Full Text] [Related]
9. Localization of the zinc finger DNA-binding protein HIV-EP1/MBP-1/PRDII-BF1 to human chromosome 6p22.3-p24. Gaynor RB, Muchardt C, Diep A, Mohandas TK, Sparkes RS, Lusis AJ. Genomics; 1991 Apr 25; 9(4):758-61. PubMed ID: 2037300 [Abstract] [Full Text] [Related]
10. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells. Kelly GD, Morris CB, Offermann MK. Virology; 1999 Oct 10; 263(1):128-38. PubMed ID: 10544088 [Abstract] [Full Text] [Related]
11. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Doerre S, Sista P, Sun SC, Ballard DW, Greene WC. Proc Natl Acad Sci U S A; 1993 Feb 01; 90(3):1023-7. PubMed ID: 8430069 [Abstract] [Full Text] [Related]
12. HIV-EP2, a new member of the gene family encoding the human immunodeficiency virus type 1 enhancer-binding protein. Comparison with HIV-EP1/PRDII-BF1/MBP-1. Nomura N, Zhao MJ, Nagase T, Maekawa T, Ishizaki R, Tabata S, Ishii S. J Biol Chem; 1991 May 05; 266(13):8590-4. PubMed ID: 2022670 [Abstract] [Full Text] [Related]
13. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism. Maciaszek JW, Talmage DA, Viglianti GA. J Virol; 1994 Oct 05; 68(10):6598-604. PubMed ID: 8083995 [Abstract] [Full Text] [Related]
15. Differential transcriptional activation in vitro by NF-kappa B/Rel proteins. Lin R, Gewert D, Hiscott J. J Biol Chem; 1995 Feb 17; 270(7):3123-31. PubMed ID: 7852394 [Abstract] [Full Text] [Related]
16. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ. EMBO J; 1993 Sep 17; 12(9):3551-8. PubMed ID: 8253080 [Abstract] [Full Text] [Related]
17. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli. Mallardo M, Dragonetti E, Baldassarre F, Ambrosino C, Scala G, Quinto I. J Biol Chem; 1996 Aug 23; 271(34):20820-7. PubMed ID: 8702837 [Abstract] [Full Text] [Related]
18. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms. Chang LJ, McNulty E, Martin M. J Virol; 1993 Feb 23; 67(2):743-52. PubMed ID: 8419644 [Abstract] [Full Text] [Related]
19. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Tesmer VM, Rajadhyaksha A, Babin J, Bina M. Proc Natl Acad Sci U S A; 1993 Aug 01; 90(15):7298-302. PubMed ID: 8346247 [Abstract] [Full Text] [Related]
20. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B. Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770 [Abstract] [Full Text] [Related] Page: [Next] [New Search]